Vamshi Yelavarthi, MD
Pain Medicine · San Tan Valley, AZNPI 1114311149
Payments from drug & device makers
Across 326 payments — averaging $25.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Biotronik NRO, Inc.$1K
- Nalu Medical, Inc.$1K
- Medtronic$843
- AbbVie$619
- Boston Scientific$617
- plus $2K from 29 others
What the payments were for
- Travel & lodging$431%
- Food & beverage$8,01596%
- Education$2613%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 81 | $1,947 |
| Biotronik NRO, Inc. | 36 | $1,210 |
| Nalu Medical, Inc. | 40 | $1,012 |
| Medtronic(2 entities) | 24 | $843 |
| AbbVie | 41 | $619 |
| Boston Scientific | 24 | $617 |
| Vertos Medical, Inc. | 4 | $444 |
| Collegium Pharmaceutical, Inc. | 27 | $404 |
| Relievant Medsystems, Inc. | 4 | $242 |
| Nevro Corp. | 5 | $143 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $118 |
| Hikma Pharmaceuticals USA | 5 | $90 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| Ultragenyx Pharmaceutical Inc. | 2 | $51 |
| Bioventus LLC | 1 | $47 |
| GRT US Holding, Inc. | 2 | $44 |
| Ferring Pharmaceuticals Inc. | 2 | $41 |
| Protega Pharmaceutials Inc | 1 | $41 |
| Painteq LLC | 1 | $35 |
| Lundbeck LLC | 1 | $31 |
| SPR Therapeutics, Inc | 1 | $30 |
| Avanos Medical | 1 | $26 |
| Redhill Biopharma Inc. | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Vertex | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Orthogenrx Inc. | 1 | $18 |
| Spinal Simplicity, LLC | 1 | $18 |
| Si-bone, Inc. | 1 | $16 |
| Amgen | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Novartis | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
| Foundation Fusion Solutions, LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prospera$750
- Intracept$523
- Proclaim Family of SCS IPGs$522
- Nalu Neurostimulation System$363
- mild Device Kit$343
- PROCLAIM$263
- PROTG$129
- Axium INS DRG IPG$126
- SPECTRA WAVEWRITER$120
- Proclaim IPG$118
- INTELLIS ADAPTIVESTIM$117
- BIOTRONIK$113
How this compares
$8,318 in reported general payments places this provider in the 65th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 15 | $7,772 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 278 | $6,033 |
| Gabapentin | 332 | $4,844 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 134 | $4,166 |
| Pregabalin | 167 | $3,409 |
| Oxycodone Hcl | 176 | $2,761 |
| Celecoxib | 25 | $1,250 |
| Cyclobenzaprine Hcl | 100 | $1,137 |
| Tizanidine Hcl | 88 | $1,055 |
| Duloxetine Hcl | 36 | $977 |
| Baclofen | 46 | $850 |
| Tramadol Hcl | 130 | $807 |
| Morphine Sulfate | 30 | $780 |
| Morphine Sulfate ErMorphine Sulfate | 37 | $762 |
| Methocarbamol | 32 | $338 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $404 | $7,77215 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $90 | $78030 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 180 pain medicine providers in Arizona.
Other pain medicine in San Tan Valley
- Gobi ParamanandamPhoenix$2.7M
- Efrain CubilloTucson$694K
- Eric CornidezTucson$581K
- Mohab IbrahimTucson$387K
- Selaiman NooriLake Havasu City$265K
- Tory McJunkinScottsdale$218K
- Minesh ZaveriPhoenix$187K
- Chad PletnickOro Valley$137K
- Tristan PicoChandler$121K
- Daniel KreinerPhoenix$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.